Clinical audit of breast cancer patients treated with helical tomotherapy for irradiation of the internal mammary chain
- 28 March 2022
- journal article
- research article
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 22, 1-7
Abstract
Aim: To evaluate efficacy of helical tomotherapy (HT) for treatment of breast cancer with internal mammary lymph node involvement. Methods: This is a retrospective clinical audit of planning, dosimetry, toxicity and short-term survival of a cohort of 65 patients. Patients were treated between November 2014 and May 2019. The primary and nodal region was prescribed a dose of 50 Gray (Gy) in 25 fractions, while all cases of breast conserving surgery received a simultaneous integrated boost to a dose of 61 Gy in 25 fractions. Results: The 95% coverage for the primary, supraclavicular, internal mammary node and tumour bed was 93·4%, 96·8%, 90·7% and 98·3%, respectively. Mean dose to total lung, heart and contra-lateral breast was 10·6 Gy, 6·92 Gy and 4·32 Gy, respectively. None developed grade III skin or oesophageal toxicity. Twenty-one patients had progression; of which eighteen developed only distant failure while three also had loco-regional recurrence. At a median follow-up of 36 months, the 3-year loco-regional control, disease-free survival and overall survival were 93·5, 73·9 and 85·9%, respectively. Conclusion: We report encouraging clinical outcome for patients treated uniformly with HT. The predominant pattern of failure was distant metastases which suggests the need for systemic control intensification.Keywords
This publication has 27 references indexed in Scilit:
- Consideration of Dose Limits for Organs at Risk of Thoracic Radiotherapy: Atlas for Lung, Proximal Bronchial Tree, Esophagus, Spinal Cord, Ribs, and Brachial PlexusInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Simultaneous integrated boost in breast conserving treatment of breast cancer: A dosimetric comparison of helical tomotherapy and three-dimensional conformal radiotherapyRadiotherapy and Oncology, 2010
- Helical Tomotherapy Planning for Left-Sided Breast Cancer Patients With Positive Lymph Nodes: Comparison to Conventional Multiport Breast TechniqueInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: Dosimetric evaluationRadiotherapy and Oncology, 2009
- Technique alternatives for breast radiation oncology: Conventional radiation therapy to tomotherapyJournal of Medical Physics, 2009
- Three-Dimensional Conformal Simultaneously Integrated Boost Technique for Breast-Conserving RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non–small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trialRadiotherapy and Oncology, 2000
- Prognosis of Breast Cancer Patients after Mastectomy and Dissection of Internal Mammary NodesAnnals of Surgery, 1985